Xu DE - Search Results

1

Mitochondrial Dysfunction in Neural Injury.

Zhao XY, Lu MH, Yuan DJ, Xu DE, Yao PP, Ji WL, Chen H, Liu WL, Yan CX, Xia YY, Li S, Tao J, Ma QH. Zhao XY, et al. Among authors: xu de. Front Neurosci. 2019 Feb 4;13:30. doi: 10.3389/fnins.2019.00030. eCollection 2019. Front Neurosci. 2019. PMID: 30778282 Free PMC article. Review.

2

Immunotherapy for Alzheimer's disease.

Wang W, Fan L, Xu D, Wen Z, Yu R, Ma Q. Wang W, et al. Among authors: xu d. Acta Biochim Biophys Sin (Shanghai). 2012 Oct;44(10):807-14. doi: 10.1093/abbs/gms065. Epub 2012 Aug 16. Acta Biochim Biophys Sin (Shanghai). 2012. PMID: 22899646 Free article. Review.

3

Caspr interaction with Amyloid Precursor Protein reduces amyloid-β generation in vitro.

Fan LF, Xu DE, Wang WH, Yan K, Wu H, Yao XQ, Xu RX, Liu CF, Ma QH. Fan LF, et al. Among authors: xu de, xu rx. Neurosci Lett. 2013 Aug 26;548:255-60. doi: 10.1016/j.neulet.2013.05.055. Epub 2013 Jun 6. Neurosci Lett. 2013. PMID: 23748076

4

Amyloid precursor protein at node of Ranvier modulates nodal formation.

Xu DE, Zhang WM, Yang ZZ, Zhu HM, Yan K, Li S, Bagnard D, Dawe GS, Ma QH, Xiao ZC. Xu DE, et al. Cell Adh Migr. 2014;8(4):396-403. doi: 10.4161/cam.28802. Cell Adh Migr. 2014. PMID: 25482638 Free PMC article.

5

Structure and function of the contactin-associated protein family in myelinated axons and their relationship with nerve diseases.

Zou Y, Zhang WF, Liu HY, Li X, Zhang X, Ma XF, Sun Y, Jiang SY, Ma QH, Xu DE. Zou Y, et al. Among authors: xu de. Neural Regen Res. 2017 Sep;12(9):1551-1558. doi: 10.4103/1673-5374.215268. Neural Regen Res. 2017. PMID: 29090003 Free PMC article. Review.

6

Inhibition of sphingomyelin synthase 1 ameliorates alzheimer-like pathology in APP/PS1 transgenic mice through promoting lysosomal degradation of BACE1.

Lu MH, Ji WL, Xu DE, Yao PP, Zhao XY, Wang ZT, Fang LP, Huang R, Lan LJ, Chen JB, Wang TH, Cheng LH, Xu RX, Liu CF, Puglielli L, Ma QH. Lu MH, et al. Among authors: xu de, xu rx. Exp Neurol. 2019 Jan;311:67-79. doi: 10.1016/j.expneurol.2018.09.012. Epub 2018 Sep 20. Exp Neurol. 2019. PMID: 30243987

7

The Mitochondrion: A Potential Therapeutic Target for Alzheimer's Disease.

Lu MH, Zhao XY, Yao PP, Xu DE, Ma QH. Lu MH, et al. Among authors: xu de. Neurosci Bull. 2018 Dec;34(6):1127-1130. doi: 10.1007/s12264-018-0310-y. Epub 2018 Nov 12. Neurosci Bull. 2018. PMID: 30417261 Free PMC article. Review. No abstract available.

8

Transplantation of GABAergic Interneuron Progenitor Attenuates Cognitive Deficits of Alzheimer's Disease Model Mice.

Lu MH, Zhao XY, Xu DE, Chen JB, Ji WL, Huang ZP, Pan TT, Xue LL, Wang F, Li QF, Zhang Y, Wang TH, Yanagawa Y, Liu CF, Xu RX, Xia YY, Li S, Ma QH. Lu MH, et al. Among authors: xu de, xu rx. J Alzheimers Dis. 2020;75(1):245-260. doi: 10.3233/JAD-200010. J Alzheimers Dis. 2020. PMID: 32280096

9

Intranasal Transplantation of Human Neural Stem Cells Ameliorates Alzheimer's Disease-Like Pathology in a Mouse Model.

Lu MH, Ji WL, Chen H, Sun YY, Zhao XY, Wang F, Shi Y, Hu YN, Liu BX, Wu JW, Xu DE, Zheng JW, Liu CF, Ma QH. Lu MH, et al. Among authors: xu de. Front Aging Neurosci. 2021 Mar 10;13:650103. doi: 10.3389/fnagi.2021.650103. eCollection 2021. Front Aging Neurosci. 2021. PMID: 33776747 Free PMC article.

10

Clemastine attenuates AD-like pathology in an AD model mouse via enhancing mTOR-mediated autophagy.

Li ZY, Chen LH, Zhao XY, Chen H, Sun YY, Lu MH, Wang ZT, Chen M, Lu L, Huang W, Chen R, Xu DE, Xu RX, Ma QH. Li ZY, et al. Among authors: xu de, xu rx. Exp Neurol. 2021 Aug;342:113742. doi: 10.1016/j.expneurol.2021.113742. Epub 2021 May 6. Exp Neurol. 2021. PMID: 33965410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page